Immune Checkpoint Inhibitor-Related Pneumonia in Unresectable Hepatocellular Carcinoma: Two Fatal Cases under Atezolizumab plus Bevacizumab
Liver Cancer
.
2022 Aug 16;11(6):572-575.
doi: 10.1159/000526388.
eCollection 2022 Dec.
Authors
Kei Endo
1
,
Hidekatsu Kuroda
1
,
Takayoshi Oikawa
1
,
Yuma Ito
2
,
Tamami Abe
1
,
Youhei Kooka
1
,
Keisuke Kakisaka
1
,
Akio Miyasaka
1
,
Tamotsu Sugai
2
,
Takayuki Matsumoto
1
Affiliations
1
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Iwate Medical University School of Medicine, Yahaba, Japan.
2
Department of Molecular Diagnostic Pathology, Iwate Medical University School of Medicine, Yahaba, Japan.
PMID:
36589724
PMCID:
PMC9801177
DOI:
10.1159/000526388
No abstract available
Grants and funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.